Skip to content
10-K

Annual Report

BLACK DIAMOND THERAPEUTICS, INC. BDTX

0001701541-25-000016

← back to feed
Filed
Mar 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 28, 2025 56.66M sh
Capex FY 2024 · Dec 31, 2024 $0
Capex FY 2024 · Dec 31, 2023 $33K
Shares Diluted FY 2024 · Dec 31, 2023 43.95M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$66.72M
Cash And Equivalents FY 2024 · Dec 31, 2023 $56.22M
Current Liabilities FY 2024 · Dec 31, 2023 $19.65M
Total Liabilities FY 2024 · Dec 31, 2023 $41.83M
Current Assets FY 2024 · Dec 31, 2023 $134.03M
Total Assets FY 2024 · Dec 31, 2023 $158.57M
Eps Diluted FY 2024 · Dec 31, 2023 −$1.88
Eps Basic FY 2024 · Dec 31, 2023 −$1.88
Sga Expense FY 2024 · Dec 31, 2023 $27.11M
Rd Expense FY 2024 · Dec 31, 2023 $59.35M
Net Income FY 2024 · Dec 31, 2023 −$82.44M
Operating Income FY 2024 · Dec 31, 2023 −$86.46M
Stockholders Equity FY 2024 · Dec 31, 2022 $115.7M